tiprankstipranks
Trending News
More News >
Molecular Templates, Inc. (MTEMQ)
OTHER OTC:MTEMQ
US Market
Advertisement

Molecular Templates (MTEMQ) Price & Analysis

Compare
563 Followers

MTEMQ Stock Chart & Stats


MTEMQ FAQ

What was Molecular Templates, Inc.’s price range in the past 12 months?
Molecular Templates, Inc. lowest stock price was $0.01 and its highest was $1.59 in the past 12 months.
    What is Molecular Templates, Inc.’s market cap?
    Molecular Templates, Inc.’s market cap is $658.00.
      When is Molecular Templates, Inc.’s upcoming earnings report date?
      Molecular Templates, Inc.’s upcoming earnings report date is Aug 07, 2025 which is in 8 days.
        How were Molecular Templates, Inc.’s earnings last quarter?
        Currently, no data Available
        Is Molecular Templates, Inc. overvalued?
        According to Wall Street analysts Molecular Templates, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Molecular Templates, Inc. pay dividends?
          Molecular Templates, Inc. does not currently pay dividends.
          What is Molecular Templates, Inc.’s EPS estimate?
          Molecular Templates, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Molecular Templates, Inc. have?
          Molecular Templates, Inc. has 43,869,000 shares outstanding.
            What happened to Molecular Templates, Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Molecular Templates, Inc.?
            Currently, no hedge funds are holding shares in MTEMQ

            Company Description

            Molecular Templates, Inc.

            Molecular Templates, Inc. (MTEM) is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics. The company operates primarily in the biotechnology sector, utilizing its proprietary engineered toxin body platform technology to create novel therapies aimed at treating cancer and other serious diseases. Molecular Templates strives to enhance the potency and specificity of its therapeutics to improve patient outcomes.

            Molecular Templates (MTEMQ) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Fate Therapeutics
            Karyopharm Therapeutics
            Adaptimmune Therapeutics

            Ownership Overview

            16.57%0.61%<0.01%83.43%
            16.57%
            Insiders
            0.61%
            Mutual Funds
            <0.01% Other Institutional Investors
            83.43% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis